Small hard drusen and associated factors in early seniority.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 27 06 2022
accepted: 02 12 2022
entrez: 22 12 2022
pubmed: 23 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

The purpose of this study was to examine the ocular and systemic risk profile of the fundus phenotype ≥ 20 small hard (macular) drusen (< 63 μm in diameter). This single-center, cross-sectional study of 176 same-sex twin pairs aged 30 to 80 (median 60) years was a component of a framework study of the transition from not having age-related macular degeneration to having early AMD. Drusen categories assessed using fundus photography and optical coherence tomography included small hard drusen (diameter < 63 μm), intermediate soft drusen (63-125 μm), and large soft drusen (> 125 μm), of which the soft drusen are compatible with a diagnosis of AMD. Having ≥ 20 small hard drusen within or outside the macula was associated with increasing age, lower body mass index, shorter axial length, hyperopia, female sex, increasing high-density lipoprotein (HDL), high alcohol consumption, and with the presence of soft drusen. Having ≥ 20 small hard drusen was associated with some AMD-related risk factors, but not with smoking, increasing body mass index, and higher blood pressure. Having ≥ 20 small hard drusen was also associated with soft drusen, in agreement with previous studies. These findings suggest that small hard drusen are not an early manifestation of AMD but the product of a distinct process of tissue alteration that promotes the development of AMD or some subtype thereof.

Identifiants

pubmed: 36548342
doi: 10.1371/journal.pone.0279279
pii: PONE-D-22-18180
pmc: PMC9778563
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0279279

Informations de copyright

Copyright: © 2022 Belmouhand et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Proc Natl Acad Sci U S A. 2005 May 17;102(20):7227-32
pubmed: 15870199
Arch Ophthalmol. 2003 Jun;121(6):785-92
pubmed: 12796248
Eye (Lond). 1994;8 ( Pt 3):269-83
pubmed: 7525362
J Ophthalmol. 2013;2013:895147
pubmed: 24368940
Twin Res Hum Genet. 2019 Dec;22(6):499-507
pubmed: 31544734
Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1454-1460
pubmed: 30947335
Invest Ophthalmol Vis Sci. 2007 Feb;48(2):833-8
pubmed: 17251485
Ophthalmologica. 2022;245(5):421-430
pubmed: 35878587
Retina. 1988;8(2):102-8
pubmed: 3420310
Turk J Ophthalmol. 2018 Oct;48(5):238-244
pubmed: 30405945
Am J Clin Nutr. 2015 Nov;102(5):1196-206
pubmed: 26490493
Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1276-83
pubmed: 26990164
Arch Ophthalmol. 2003 Dec;121(12):1728-37
pubmed: 14662593
Br J Ophthalmol. 1999 Mar;83(3):358-68
pubmed: 10365048
Ophthalmology. 2006 Mar;113(3):373-80
pubmed: 16513455
Diabetologia. 2003 Sep;46(9):1276-83
pubmed: 12898014
Ophthalmology. 2013 Oct;120(10):2058-65
pubmed: 23706699
Ophthalmology. 2001 Apr;108(4):697-704
pubmed: 11297486
Am J Ophthalmol. 2008 Apr;145(4):707-715
pubmed: 18242575
Ophthalmology. 2000 Dec;107(12):2224-32
pubmed: 11097601
Invest Ophthalmol Vis Sci. 2011 Oct 31;52(11):8438-41
pubmed: 21917938
Invest Ophthalmol Vis Sci. 2008 Mar;49(3):1200-9
pubmed: 18326750
Ophthalmic Physiol Opt. 2020 Mar;40(2):140-170
pubmed: 32100327
Ophthalmol Retina. 2018 Dec;2(12):1196-1205
pubmed: 31047191
Invest Ophthalmol Vis Sci. 2012 Mar 21;53(3):1548-56
pubmed: 22247473
Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6247-52
pubmed: 20671287
Arch Ophthalmol. 1995 Mar;113(3):301-8
pubmed: 7534060
Invest Ophthalmol Vis Sci. 2013 Jun 06;54(6):3932-40
pubmed: 23652489
J Clin Med. 2015 Mar;4(3):424-40
pubmed: 25905023

Auteurs

Mohamed Belmouhand (M)

Department of Ophthalmology, Rigshospitalet, Copenhagen University Hospital, Glostrup, Denmark.
Faculty of Health and Medical Science, Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Simon P Rothenbuehler (SP)

Department of Ophthalmology, Rigshospitalet, Copenhagen University Hospital, Glostrup, Denmark.
Department of Ophthalmology, University Hospital Basel, Basel, Switzerland.

Sami Dabbah (S)

Department of Ophthalmology, Rigshospitalet, Copenhagen University Hospital, Glostrup, Denmark.

Jakob Bjerager (J)

Department of Ophthalmology, Rigshospitalet, Copenhagen University Hospital, Glostrup, Denmark.

Birgit Sander (B)

Department of Ophthalmology, Rigshospitalet, Copenhagen University Hospital, Glostrup, Denmark.

Jacob B Hjelmborg (JB)

Epidemiology, Biostatistics and Biodemography, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Danish Twin Research Center, University of Southern Denmark, Odense, Denmark.

Christine Dalgård (C)

Danish Twin Research Center, University of Southern Denmark, Odense, Denmark.
Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.

Rasmus Jensen (R)

Epidemiology, Biostatistics and Biodemography, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Department of Mathematics and Computer Science, University of Southern Denmark, Odense, Denmark.

Michael Larsen (M)

Department of Ophthalmology, Rigshospitalet, Copenhagen University Hospital, Glostrup, Denmark.
Faculty of Health and Medical Science, Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH